Skip to main content
. 2022 May 7;12(5):421. doi: 10.3390/metabo12050421

Figure 1.

Figure 1

(a) Urine and plasma sampling times after acute exposure to NU and sampling time models defined for Partial Least-Squares Discriminant Analysis (PLS-DA). (b) Data processing pipeline patterns. (c) The main objectives of this study.